A narrative review of hydrogen oncology: from real world survey to real world evidence.
Ji-Bing Chen, You-Yong Lu, Ke-Cheng Xu · Medical gas research · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This narrative review examined the available molecular-hydrogen literature. The study reported a real-world survey from 82 patients with good cancer control using hydrogen products, including real world evidence from patients who received ineffective traditional treatment, patients who received traditional treatment that failed, or patients who refused traditional treatment. The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
What the Findings Mean
H2HUBB reviewed this publication as a synthesis of molecular-hydrogen research and summarizes the outcomes emphasized by the authors. After 3 months of hydrogen inhalation, tumor markers were reduced to the normal reference range, and CT showed more than a 50% reduction in gallbladder tumors and multiple intrahepatic and hilar metastases (defined as partial response).
What the Researchers Studied
The authors reviewed a narrative review of hydrogen oncology: from real world survey to real world evidence.
What Effects Did Molecular Hydrogen Have?
After 3 months of hydrogen inhalation, tumor markers were reduced to the normal reference range, and CT showed more than a 50% reduction in gallbladder tumors and multiple intrahepatic and hilar metastases (defined as partial response). The authors concluded that the current data indicate that the immunosenescence of advanced NSCLC involves nearly all lymphocyte subsets, and 2 weeks of hydrogen treatment can significantly improve most of these indexes. Subsequently, the researchers included studies on the mechanism of hydrogen oncology. The mechanism of cancer control using hydrogen includes the inhibition of tumor cells and the activation of exhausted lymphocytes.
Why These Findings Matter
The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
How Strong Is This Evidence?
This is review or synthesis evidence (narrative review).
Technical Study Details
H2HUBB classifies this publication as narrative review with review or synthesis evidence. The reported sample size was 82. The study used a narrative review. The hydrogen delivery method was inhaled hydrogen gas.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.